These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 16951350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69.
    Amicosante M, Sanarico N, Berretta F, Arroyo J, Lombardi G, Lechler R, Colizzi V, Saltini C.
    Hum Immunol; 2001 Jul; 62(7):686-93. PubMed ID: 11423174
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease.
    Falta MT, Pinilla C, Mack DG, Tinega AN, Crawford F, Giulianotti M, Santos R, Clayton GM, Wang Y, Zhang X, Maier LA, Marrack P, Kappler JW, Fontenot AP.
    J Exp Med; 2013 Jul 01; 210(7):1403-18. PubMed ID: 23797096
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis.
    Chou YK, Edwards DM, Weinberg AD, Vandenbark AA, Kotzin BL, Fontenot AP, Burrows GG.
    J Immunol; 2005 Apr 01; 174(7):4316-24. PubMed ID: 15778396
    [Abstract] [Full Text] [Related]

  • 10. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
    Amicosante M, Berretta F, Franchi A, Rogliani P, Dotti C, Losi M, Dweik R, Saltini C.
    Eur Respir J; 2002 Nov 01; 20(5):1174-8. PubMed ID: 12449171
    [Abstract] [Full Text] [Related]

  • 11. Identification of multiple public TCR repertoires in chronic beryllium disease.
    Bowerman NA, Falta MT, Mack DG, Wehrmann F, Crawford F, Mroz MM, Maier LA, Kappler JW, Fontenot AP.
    J Immunol; 2014 May 15; 192(10):4571-80. PubMed ID: 24719461
    [Abstract] [Full Text] [Related]

  • 12. Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells.
    Amicosante M, Berretta F, Dweik R, Saltini C.
    Immunology; 2009 Sep 15; 128(1 Suppl):e462-70. PubMed ID: 19191908
    [Abstract] [Full Text] [Related]

  • 13. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
    Mandic M, Castelli F, Janjic B, Almunia C, Andrade P, Gillet D, Brusic V, Kirkwood JM, Maillere B, Zarour HM.
    J Immunol; 2005 Feb 01; 174(3):1751-9. PubMed ID: 15661941
    [Abstract] [Full Text] [Related]

  • 14. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.
    Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R.
    J Immunol; 2001 Mar 01; 166(5):3549-55. PubMed ID: 11207315
    [Abstract] [Full Text] [Related]

  • 15. Crystal structure of HLA-DP2 and implications for chronic beryllium disease.
    Dai S, Murphy GA, Crawford F, Mack DG, Falta MT, Marrack P, Kappler JW, Fontenot AP.
    Proc Natl Acad Sci U S A; 2010 Apr 20; 107(16):7425-30. PubMed ID: 20356827
    [Abstract] [Full Text] [Related]

  • 16. T cell recognition in chronic beryllium disease.
    Amicosante M, Fontenot AP.
    Clin Immunol; 2006 Nov 20; 121(2):134-43. PubMed ID: 16697706
    [Abstract] [Full Text] [Related]

  • 17. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.
    Fontenot AP, Newman LS, Kotzin BL.
    Clin Immunol; 2001 Jul 20; 100(1):4-14. PubMed ID: 11414740
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity.
    Clayton GM, Wang Y, Crawford F, Novikov A, Wimberly BT, Kieft JS, Falta MT, Bowerman NA, Marrack P, Fontenot AP, Dai S, Kappler JW.
    Cell; 2014 Jul 03; 158(1):132-42. PubMed ID: 24995984
    [Abstract] [Full Text] [Related]

  • 20. Linking genetic susceptibility and T cell activation in beryllium-induced disease.
    Falta MT, Bowerman NA, Dai S, Kappler JW, Fontenot AP.
    Proc Am Thorac Soc; 2010 May 03; 7(2):126-9. PubMed ID: 20427584
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.